This white paper from Kinova explores the industry shift from adapting industrial robots to developing purpose-built, medical-first actuation systems for surgical robotics.
It examines how the surgical robotics market is transitioning into a multi-vendor era driven by specialized OEMs, procedural diversification, and the shift toward ambulatory care.
The document highlights the limitations of traditional industrial arms, such as geometric bulk in crowded operating rooms, regulatory obstacles, and control latency, and contrasts them with modular, purpose-built solutions like the KIMA robotic arm. By utilizing purpose-built medical robotic arms with embedded controllers and precertified software standards like IEC 62304 Class C, OEMs can shave 12 to 18 months
off development cycles.
This allows them to bypass the mechanical hurdles of industrial adaptation and focus on their true value proposition, including clinical outcomes, AI-driven insights, and data-driven surgery.
Key Topics Covered
- The shift from industrial robots to purpose-built medical robotics platforms
- Challenges of adapting industrial robotic arms for surgical applications
- Trends driving the growth of specialized surgical robotics OEMs
- Benefits of modular medical-first actuation systems and embedded control architectures
- How precertified software and robotic platforms can accelerate development and regulatory readiness
